The influence of indapamide on serum lipoproteins in essential hypertension. 1984

W Meyer-Sabellek, and J Heitz, and J R Arntz, and K L Schulte, and R Gotzen

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007190 Indapamide A benzamide-sulfonamide-indole derived DIURETIC that functions by inhibiting SODIUM CHLORIDE SYMPORTERS. Metindamide,S-1520,SE-1520,S 1520,S1520,SE 1520,SE1520
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D004232 Diuretics Agents that promote the excretion of urine through their effects on kidney function. Diuretic,Diuretic Effect,Diuretic Effects,Effect, Diuretic,Effects, Diuretic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014280 Triglycerides An ester formed from GLYCEROL and three fatty acid groups. Triacylglycerol,Triacylglycerols,Triglyceride

Related Publications

W Meyer-Sabellek, and J Heitz, and J R Arntz, and K L Schulte, and R Gotzen
January 1989, Clinical therapeutics,
W Meyer-Sabellek, and J Heitz, and J R Arntz, and K L Schulte, and R Gotzen
January 1983, European journal of clinical pharmacology,
W Meyer-Sabellek, and J Heitz, and J R Arntz, and K L Schulte, and R Gotzen
June 1993, Journal of human hypertension,
W Meyer-Sabellek, and J Heitz, and J R Arntz, and K L Schulte, and R Gotzen
January 1985, Hypertension (Dallas, Tex. : 1979),
W Meyer-Sabellek, and J Heitz, and J R Arntz, and K L Schulte, and R Gotzen
October 2006, Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences,
W Meyer-Sabellek, and J Heitz, and J R Arntz, and K L Schulte, and R Gotzen
January 1981, Postgraduate medical journal,
W Meyer-Sabellek, and J Heitz, and J R Arntz, and K L Schulte, and R Gotzen
July 1983, American heart journal,
W Meyer-Sabellek, and J Heitz, and J R Arntz, and K L Schulte, and R Gotzen
December 1981, British journal of clinical pharmacology,
W Meyer-Sabellek, and J Heitz, and J R Arntz, and K L Schulte, and R Gotzen
December 1982, Minerva cardioangiologica,
W Meyer-Sabellek, and J Heitz, and J R Arntz, and K L Schulte, and R Gotzen
October 1981, British heart journal,
Copied contents to your clipboard!